Medtronic Plc Stock Z Score

MDT Stock

USD 78.72 0.36 0.46%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Medtronic PLC Piotroski F Score and Medtronic PLC Valuation analysis.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

At this time, Medtronic PLC's Capital Expenditures is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 458.4 M in 2024, whereas Net Invested Capital is likely to drop slightly above 61.9 B in 2024. At this time, Medtronic PLC's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 6.5 B in 2024, whereas Selling General Administrative is likely to drop slightly above 7.5 B in 2024.

Medtronic PLC Company Z Score Analysis

Medtronic PLC's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Medtronic Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Medtronic PLC is extremely important. It helps to project a fair market value of Medtronic Stock properly, considering its historical fundamentals such as Z Score. Since Medtronic PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medtronic PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medtronic PLC's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Long Term Debt	Good Will	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Deferred Long Term Liab	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Cash And Equivalents	Net Working Capital
Total Assets		0.99	0.97	0.78	0.9	0.99	0.88	0.15	0.91	0.87	0.98	0.98	0.37	-0.97	0.86	0.43	-0.71	-0.87	0.14	0.5	-0.69	-0.61	-0.54	-0.49	0.49
Total Stockholder Equity	0.99		0.94	0.74	0.9	0.96	0.86	0.08	0.87	0.91	0.95	0.99	0.3	-0.97	0.89	0.32	-0.78	-0.89	0.21	0.4	-0.77	-0.7	-0.62	-0.57	0.56
Net Debt	0.97	0.94		0.85	0.89	0.99	0.9	0.2	0.93	0.78	0.99	0.92	0.47	-0.91	0.78	0.6	-0.55	-0.8	0.06	0.65	-0.53	-0.45	-0.4	-0.39	0.37
Retained Earnings	0.78	0.74	0.85		0.78	0.82	0.8	-0.03	0.79	0.57	0.86	0.71	0.59	-0.69	0.61	0.62	-0.29	-0.7	-0.02	0.72	-0.2	-0.18	-0.2	-0.21	0.13
Net Receivables	0.9	0.9	0.89	0.78		0.89	0.92	0.03	0.74	0.81	0.89	0.86	0.48	-0.8	0.81	0.3	-0.58	-0.74	0.16	0.36	-0.56	-0.55	-0.54	-0.51	0.5
Total Liab	0.99	0.96	0.99	0.82	0.89		0.9	0.22	0.94	0.8	0.99	0.95	0.45	-0.94	0.79	0.55	-0.61	-0.82	0.05	0.62	-0.59	-0.49	-0.42	-0.38	0.4
Total Current Assets	0.88	0.86	0.9	0.8	0.92	0.9		0.17	0.78	0.7	0.89	0.81	0.72	-0.79	0.7	0.44	-0.5	-0.65	0.05	0.52	-0.46	-0.4	-0.36	-0.32	0.31
Short Term Debt	0.15	0.08	0.2	-0.03	0.03	0.22	0.17		0.24	-0.12	0.06	0.04	0.15	-0.13	-0.19	0.48	0.11	0.28	-0.36	0.38	-0.05	0.21	0.36	0.42	-0.5
Intangible Assets	0.91	0.87	0.93	0.79	0.74	0.94	0.78	0.24		0.62	0.93	0.87	0.41	-0.92	0.61	0.66	-0.52	-0.79	-0.15	0.76	-0.48	-0.31	-0.25	-0.18	0.28
Accounts Payable	0.87	0.91	0.78	0.57	0.81	0.8	0.7	-0.12	0.62		0.8	0.92	0.1	-0.85	0.98	0.04	-0.83	-0.85	0.53	0.07	-0.85	-0.9	-0.83	-0.83	0.7
Long Term Debt	0.98	0.95	0.99	0.86	0.89	0.99	0.89	0.06	0.93	0.8		0.94	0.46	-0.93	0.81	0.53	-0.6	-0.87	0.07	0.62	-0.54	-0.48	-0.44	-0.42	0.46
Good Will	0.98	0.99	0.92	0.71	0.86	0.95	0.81	0.04	0.87	0.92	0.94		0.24	-0.98	0.9	0.3	-0.8	-0.92	0.23	0.38	-0.79	-0.72	-0.64	-0.6	0.59
Short Term Investments	0.37	0.3	0.47	0.59	0.48	0.45	0.72	0.15	0.41	0.1	0.46	0.24		-0.26	0.11	0.52	0.05	-0.12	-0.26	0.57	0.18	0.22	0.23	0.19	-0.18
Common Stock	-0.97	-0.97	-0.91	-0.69	-0.8	-0.94	-0.79	-0.13	-0.92	-0.85	-0.93	-0.98	-0.26		-0.82	-0.37	0.8	0.9	-0.11	-0.46	0.76	0.64	0.52	0.48	-0.51
Property Plant Equipment	0.86	0.89	0.78	0.61	0.81	0.79	0.7	-0.19	0.61	0.98	0.81	0.9	0.11	-0.82		0.06	-0.78	-0.86	0.52	0.09	-0.77	-0.86	-0.8	-0.83	0.71
Current Deferred Revenue	0.43	0.32	0.6	0.62	0.3	0.55	0.44	0.48	0.66	0.04	0.53	0.3	0.52	-0.37	0.06		0.19	-0.18	-0.45	0.95	0.2	0.36	0.38	0.35	-0.38
Long Term Investments	-0.71	-0.78	-0.55	-0.29	-0.58	-0.61	-0.5	0.11	-0.52	-0.83	-0.6	-0.8	0.05	0.8	-0.78	0.19		0.78	-0.36	0.1	0.9	0.86	0.67	0.65	-0.72
Short Long Term Debt	-0.87	-0.89	-0.8	-0.7	-0.74	-0.82	-0.65	0.28	-0.79	-0.85	-0.87	-0.92	-0.12	0.9	-0.86	-0.18	0.78		-0.24	-0.32	0.68	0.68	0.63	0.62	-0.69
Net Tangible Assets	0.14	0.21	0.06	-0.02	0.16	0.05	0.05	-0.36	-0.15	0.53	0.07	0.23	-0.26	-0.11	0.52	-0.45	-0.36	-0.24		-0.49	-0.47	-0.66	-0.72	-0.78	0.45
Deferred Long Term Liab	0.5	0.4	0.65	0.72	0.36	0.62	0.52	0.38	0.76	0.07	0.62	0.38	0.57	-0.46	0.09	0.95	0.1	-0.32	-0.49		0.17	0.33	0.34	0.35	-0.29
Long Term Debt Total	-0.69	-0.77	-0.53	-0.2	-0.56	-0.59	-0.46	-0.05	-0.48	-0.85	-0.54	-0.79	0.18	0.76	-0.77	0.2	0.9	0.68	-0.47	0.17		0.92	0.81	0.71	-0.63
Capital Surpluse	-0.61	-0.7	-0.45	-0.18	-0.55	-0.49	-0.4	0.21	-0.31	-0.9	-0.48	-0.72	0.22	0.64	-0.86	0.36	0.86	0.68	-0.66	0.33	0.92		0.92	0.89	-0.77
Net Invested Capital	-0.54	-0.62	-0.4	-0.2	-0.54	-0.42	-0.36	0.36	-0.25	-0.83	-0.44	-0.64	0.23	0.52	-0.8	0.38	0.67	0.63	-0.72	0.34	0.81	0.92		0.88	-0.78
Cash And Equivalents	-0.49	-0.57	-0.39	-0.21	-0.51	-0.38	-0.32	0.42	-0.18	-0.83	-0.42	-0.6	0.19	0.48	-0.83	0.35	0.65	0.62	-0.78	0.35	0.71	0.89	0.88		-0.76
Net Working Capital	0.49	0.56	0.37	0.13	0.5	0.4	0.31	-0.5	0.28	0.7	0.46	0.59	-0.18	-0.51	0.71	-0.38	-0.72	-0.69	0.45	-0.29	-0.63	-0.77	-0.78	-0.76

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Medtronic PLC

Based on the company's disclosures, Medtronic PLC has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Medtronic PLC ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medtronic PLC's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medtronic PLC's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Medtronic PLC Institutional Holders

Institutional Holdings refers to the ownership stake in Medtronic PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medtronic PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medtronic PLC's value.

		Shares
Franklin Resources Inc	2023-12-31	19.4 M
Deutsche Bank Ag	2023-12-31	17.3 M
T. Rowe Price Associates, Inc.	2023-12-31	15.4 M
Norges Bank	2023-12-31	14.9 M
Wells Fargo & Co	2023-12-31	13.1 M
Northern Trust Corp	2023-12-31	12.7 M
Sanders Capital, Llc	2023-12-31	12.6 M
Royal Bank Of Canada	2023-12-31	12.6 M
Goldman Sachs Group Inc	2023-12-31	12 M
Vanguard Group Inc	2023-12-31	126.5 M
Blackrock Inc	2023-12-31	118.6 M

Medtronic Fundamentals

	Return On Equity	0.0817
	Return On Asset	0.0423
	Profit Margin	0.13 %
	Operating Margin	0.19 %
	Current Valuation	122.29 B
	Shares Outstanding	1.33 B
	Shares Owned By Insiders	0.10 %
	Shares Owned By Institutions	85.17 %
	Number Of Shares Shorted	12.43 M
	Price To Earning	20.44 X
	Price To Book	2.05 X
	Price To Sales	3.29 X
	Revenue	31.23 B
	Gross Profit	21.71 B
	EBITDA	9.04 B
	Net Income	3.78 B
	Cash And Equivalents	1.54 B
	Cash Per Share	8.59 X
	Total Debt	24.36 B
	Debt To Equity	0.51 %
	Current Ratio	1.76 X
	Book Value Per Share	38.95 X
	Cash Flow From Operations	6.04 B
	Short Ratio	1.96 X
	Earnings Per Share	3.15 X
	Price To Earnings To Growth	1.52 X
	Target Price	94.11
	Number Of Employees	95 K
	Beta	0.78
	Market Capitalization	105.23 B
	Total Asset	90.95 B
	Retained Earnings	30.39 B
	Working Capital	12.62 B
	Current Asset	23.6 B
	Current Liabilities	7.17 B
	Annual Yield	0.03 %
	Five Year Return	2.18 %
	Net Asset	90.95 B
	Last Dividend Paid	2.75

About Medtronic PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:

How To Invest In Medtronic

Details

Is Medtronic Stock a good investment?

Details

What is Medtronic PLC's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Medtronic PLC Piotroski F Score and Medtronic PLC Valuation analysis.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Medtronic Stock analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins

Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.078

Dividend Share

2.75

Earnings Share

3.15

Revenue Per Share

24.298

Quarterly Revenue Growth

0.047

The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medtronic Plc Stock Z Score

Medtronic PLC Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Medtronic Z Score Driver Correlations

Medtronic PLC ESG Sustainability

Medtronic PLC Institutional Holders

Medtronic Fundamentals

About Medtronic PLC Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Medtronic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY